-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CGc9zA0YeotNOxkc5oFfAly8FkI4GyOiW34Xo6SxxabQSVO8308X+OEkFHbB4rfI nA0G2+QHCpkevM7Cn/5B1w== 0000932440-00-000075.txt : 20000215 0000932440-00-000075.hdr.sgml : 20000215 ACCESSION NUMBER: 0000932440-00-000075 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VIROPHARMA INC CENTRAL INDEX KEY: 0000946840 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232789550 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-48239 FILM NUMBER: 541308 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BLVD STREET 2: PO BOX 5000 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104587300 MAIL ADDRESS: STREET 1: 76 GREAT VALLEY PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW YORK LIFE INSURANCE CO CENTRAL INDEX KEY: 0000071633 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 135582869 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 51 MADISON AVE ROOM 207 STREET 2: ATTN INVESTMENT DEPT VENTURE CAP GROUP CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2125766806 MAIL ADDRESS: STREET 1: 51 MADISON AVE ROOM 207 STREET 2: ATTN INVESTMENT DEPT VENTURE CAP GROUP CITY: NEW YORK STATE: NY ZIP: 10010 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13D-102) INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2)* VIROPHARMA INCORPORATED (Name of Issuer) COMMON STOCK (Title of Class of Securities) 928241108 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUPSIP NO. 928241108 PAGE 2 OF 4 VIROPHARMA INCORPORATED 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON NEW YORK LIFE INSURANCE COMPANY 13-5582869 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK NUMBER OF 5. SOLE VOTING POWER 299,397 SHARES BENEFICIALLY 6. SHARED VOTING POWER 0 OWNED BY EACH 7. SOLE DISPOSITIVE POWER 299,397 REPORTING PERSON 8. SHARED DISPOSITIVE POWER 0 WITH 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 299,397 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 2% 12. TYPE OF REPORTING PERSON* IC *SEE INSTRUCTIONS BEFORE FILLING OUT SCHEDULE 13G CUPSIP NO. 928241108 PAGE 3 OF 4 VIROPHARMA INCORPORATED Item 1(a) Name of issuer: VIROPHARMA INCORPORATED Item 1(b) Address of issuer's principal executive offices: 405 EAGLEVIEW BOULEVARD EXTON, PA 19341 Item 2(a) Name of person filing: NEW YORK LIFE INSURANCE COMPANY Item 2(b) Address of principal business office: 51 MADISON AVENUE, ROOM 206 NEW YORK, NY 10010 Item 2(c) Citizenship: NEW YORK Item 2(d) Title of class of securities: COMMON STOCK Item 2(e) Cusip No.: 928241108 Item 3 Type of Person: INSURANCE COMPANY AS DEFINED IN SECTION 3(A)(19) OF THE ACT Item 4(a) Amount beneficially owned: 299,397 Item 4(b) Percent of class: 2% Item 4(c) (i) sole power to vote: 299,397 (ii) shared power to vote: 0 (iii) sole power to dispose: 299,397 (iv) shared power to dispose: 0 Item 5 Ownership of 5 percent or less of a class: IF THIS STATEMENT IS BEING FILED TO REPORT THE FACT THAT AS OF THE DATE HEREOF THE REPORTING PERSON HAS CEASED TO BE THE BENEFICIAL OWNER OF MORE THAN FIVE PERCENT OF THE CLASS SECURITIES, CHECK THE FOLLOWING (X). Item 6 Ownership of more than 5 percent on behalf of another person: NOT APPLICABLE Item 7 Identification and classification of subsidiary: NOT APPLICABLE Item 8 Identification and classification of members of the group: NOT APPLICABLE Item 9 Notice of dissolution of the group: NOT APPLICABLE SCHEDULE 13G CUPSIP NO. 928241108 PAGE 4 OF 4 VIROPHARMA INCORPORATED Item 10 Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: February 10, 2000 NEW YORK LIFE INSURANCE COMPANY By: /S/ RICHARD DRAKE -------------------------------- Name: Richard Drake Title: Director -----END PRIVACY-ENHANCED MESSAGE-----